• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

1.170 -0.020 (-1.68%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 72,126
Open 1.210
Bid (Size) 1.160 (100)
Ask (Size) 1.210 (200)
Prev. Close 1.190
Today's Range 1.160 - 1.210
52wk Range 0.6138 - 2.350
Shares Outstanding 365,173,471
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
December 31, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates
November 14, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+2.6%
+2.6%
1 Month
+2.6%
+2.6%
3 Month
-33.5%
-33.5%
6 Month
+8.3%
+8.3%
1 Year
+9.3%
+9.3%

More News

Read More
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
September 22, 2025
Via Benzinga
News headline image
Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months
September 22, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
Why Did Allarity Therapeutics Stock Double In Value Today? ↗
August 26, 2025
Via Stocktwits
News headline image
Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025
September 17, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
August 27, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
August 27, 2025
Via Benzinga
News headline image
Top stock movements in today's session. ↗
August 26, 2025
Via Chartmill
News headline image
Check out the stocks that are attracting the most attention and driving market activity. ↗
August 26, 2025
Via Chartmill
News headline image
Power Metallic’s (TSX-V: PNPN | OTCQB: PNPNF) Strategic Appointment Signals Major Paradigm Shift Ahead – More Stocks Inside
August 26, 2025
Via AB Newswire
Topics Government
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
August 26, 2025
Via Benzinga
News headline image
Tuesday's session: top gainers and losers ↗
August 26, 2025
Via Chartmill
News headline image
Crude Oil Down 2%; US Durable Goods Orders Decline In July ↗
August 26, 2025
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
August 26, 2025
Via Chartmill
News headline image
US Stocks Mixed; American Woodmark Posts Downbeat Sales ↗
August 26, 2025
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
August 26, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 26, 2025
Via Benzinga
News headline image
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer
August 26, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Stock Market Today: S&P 500, Nasdaq Futures Decline— Palo Alto, XP, Allarity Earnings In Focus ↗
August 18, 2025
Via Benzinga
Topics Stocks
News headline image
Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday ↗
August 18, 2025
Via Benzinga
News headline image
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
August 15, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
July 28, 2025
Via Benzinga
News headline image
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
July 15, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
July 07, 2025
From Allarity Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Allarity Therapeutics, Inc. - Common stock publicly traded?
Yes, Allarity Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Allarity Therapeutics, Inc. - Common stock trade on?
Allarity Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Allarity Therapeutics, Inc. - Common stock?
The ticker symbol for Allarity Therapeutics, Inc. - Common stock is ALLR on the Nasdaq Stock Market
What is the current price of Allarity Therapeutics, Inc. - Common stock?
The current price of Allarity Therapeutics, Inc. - Common stock is 1.170
When was Allarity Therapeutics, Inc. - Common stock last traded?
The last trade of Allarity Therapeutics, Inc. - Common stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Allarity Therapeutics, Inc. - Common stock?
The market capitalization of Allarity Therapeutics, Inc. - Common stock is 427.25M
How many shares of Allarity Therapeutics, Inc. - Common stock are outstanding?
Allarity Therapeutics, Inc. - Common stock has 427M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap